Pharmaceutical

Who thinks outside the box to get more in it?

阿里彩票登陆平台 www.o1e1e.com.cn We do!
Our pharmaceutical team prides itself on advancing drug delivery with sophisticated science-based solutions.  Our global centers of excellence contain the latest equipment and our research scientists and formulators are ready to work with you from concept to commercialization. Now sold as Klucel™, Ashland introduced hydroxypropylcellulose (HPC) - an excipient that changed the drug delivery platform - to the market 65 years ago. And while others have followed, it was the solvers at Ashland who discovered it. Our full line of products combined with our global research and development capabilities can help deliver your drugs when and where they're needed resulting in better outcomes for patients and pharmaceutical companies alike. With its significant history in pharmaceuticals and one of the widest available range of products for oral solid-dosage forms Ashland has a solid foundation to help find excipient and formulation solutions for you. Our global manufacturing sites, that operate in accordance with cGMP standards, provide consistently high quality products regardless of origin. As a full-service resource, Ashland can help you bind, coat, dissolve and deliver solutions that can yield better patient outcomes.

 

read more >

  • Oral Solid Dosage Form

    Prescriptions for successful solutions

    While an apple a day keeps the doctor away (and the teacher happy) there comes a time, in almost everyone's life, when medication - in tablet form - is needed.  Our knowledge of the structure function of polymers, combined with our extensive product line can help you bind, coat, dissolve, and effectively deliver complex drug molecules where and when they're needed - making medication easier to swallow.  And, easy to swallow medication often yields better patient compliance,  which, in turn, yields better outcomes for everyone - a winning scenario. From concept to commericialization, working with Ashland makes medicine easy to swallow.

    Ashland is unsurpassed in its ability to develop solutions for effective and efficient solutions to deliver today's complex drug molecules where and when they are needed.  Our centers of excellence and manufacturing sites operate in accordance with cGMP standards. Our various chemistries and technologies are supported by a global team of research and development scientists. Ashland stands ready collaborate with you on new solutions to help take you from concept to commercialization.  Our solutions include:

    • Increasing the solubility of active pharmaceutical ingredients with low or no solubility
    • Designing modified-release products to meet targeted release profiles
    • Reducing tablet size while maintaining active pharmaceutical ingredient load
    • Improving disintegration time of orally disintegrating tablets
    • Understanding implications of continuous manufacturing technology for oral dosage production

    Ongoing research provides a foundation for advanced technical solutions to address these and future formulation and manufacturing challenges. Ashland provides formulators with industry-changing technologies and unique opportunities for research and development collaboration.

     

    Read More >
  • Oral Liquid Dosage Form

    Ashland helps the medicine go down

    A spoonful of sugar may help the medicine go down, but the folks at Ashland, with their expertise in pharmaceutical formulations, know that there's more to it.   Effective drug delivery in liquid form, poses some unique challenges with rheology, texture, consistency and stability at the top of the list.  Ashland's motto - We are solvers - is also our attitude and goal and we want to work with you to find new sophisticated solutions to advance drug delivery. With our extensive polymer portfolio, R&D capaitilities and testing facilities combined with your complex drug molecues can yield solutions for effective, useable ways to deliver and improve the bioavailability of  needed medication.

    Targeted rheology, texture and stabilization in oral-liquid dosage forms play vital roles in delivery of the pharmaceutical components. The water binding and viscosity modification capacities of many of Ashland’s polymers thicken and suspend in liquids, gels, syrups and semi-solid dosage forms for improved patient satisfaction and shelf life of products. Contact us to learn more.

     

    Read More >
  • Other Dosage Form

    Solutions that are more than skin deep

    Our solutions are more than skin deep.  Through transdermal and topical  applications, skin can be an effective way to deliver some medications.   Regardless of whether the drug is being delivered via gel, lotion, cream, ointment or foam, features including texture, adhesion,  and spreadability, as well as feel and smell, are important attributes to  consider for optimal patient compliance. For topical and transdermal application, Ashland's pharmacuetical team works with the talented skin care team to find alluring and luxurious ways to effectively and efficiently formulate topical and transdermal applications.

    Topical treatments are administered to skin or mucous membranes to alleviate a variety of conditions. These treatments broadly encompass creams, foams, gels, lotions and ointments. There are a number of sought-after attributes for conferring desired properties to a topical formulation: rheology control, spreadability, adhesion and diffusion control. Ashland offers high-quality cellulose ethers such as Natrosol™ 250 hydroxyethylcellulose, Klucel™ hydroxypropylcellulose and Aqualon™ sodium carboxymethylcellulose to deliver these properties. Some of the topical film formers offered in our skin-care product lines are also suitable for use in topical applications. Plasdone™ povidone is also a good film former for topical applications. Contact us to learn more about our solutions for topical and transdermal applications.

    Read More >

Learn more about our solutions


Related Content

  • 幻想成真:科学家证明动物之间记忆转移可行 2018-12-15
  • 解析视频播控平台黑产链 20元看12家网站VIP会员视频 2018-12-14
  • 十年长出一座绿色新城(在习近平新时代中国特色社会主义思想指引下——新时代新作为新篇章) 2018-12-14
  • [洞见]草榴死了 欲望还活着草榴性 2018-12-14
  • 全省首张“自助”营业执照在南海诞生 2018-12-14
  • 观众对三观不正影视剧不买账 76.7%受访者拒看 2018-12-13
  • 市民教育系列活动启动 传承弘扬中华文化做文明有礼天津人 2018-12-13
  • 白俄罗斯成“网红” 但我只想去这个超小众国家用亚洲物价玩欧洲! 2018-12-13
  • 说的有道理 。说明我们的教育方向确实是有问题,毛主席当年对教育领域的有关指示是正确的。 2018-12-12
  • 俄媒:普京邀金正恩访俄 借世界杯推动主场外交 2018-12-12
  • 东嘎寺看藏戏文章中国国家地理网 2018-12-12
  • “金特会”为何选址新加坡 2018-12-11
  • 保险销售误导和理赔难,严查! 2018-12-11
  • 陈坤时隔九年《脱身》中重返荧屏 一人分饰两角有方法 2018-12-10
  • 韩国足协主席昨称与中日朝商议联办2030年世界杯 2018-12-10
  • 104| 259| 167| 807| 526| 315| 758| 133| 995| 618|